查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771662

美国高级创伤护理OTC 市场规模、份额、趋势分析报告：按产品、应用、分销管道和细分市场预测，2025-2033 年

U.S. Advanced Wound Care OTC Market Size, Share & Trends Analysis Report By Product, By Application, By Distribution Channel, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国非处方高级创伤护理市场摘要

预计 2024 年美国先进创伤护理OTC 市场规模为 27.7 亿美元，到 2033 年将达到 66.1 亿美元，2025 年至 2033 年的复合年增长率为 10.33%。成长的动力来自于急性伤口的增加，包括外科性创伤、创伤伤口和烧烫伤，这些伤口需要有效、快速的伤口管理解决方案。

在全球范围内，交通事故、运动伤害和外科手术的增多，推动了对能够加速伤口癒合并降低感染风险的先进非处方创伤护理产品的需求激增。根据全家护理中心（Total Family Care Center）2025年4月发布的数据，美国每年约有1,100万人遭遇急性伤口，其中约30万人需要住院治疗。此外，消费者对正确创伤护理实务的认识不断提高，以及透过零售药局和线上平台轻鬆取得先进敷料，也持续支撑着市场扩张。

美国糖尿病盛行率高且持续上升，是市场成长的主要驱动力。糖尿病是导致慢性伤口（尤其是糖尿病足溃疡）的重要风险因素，及时有效的伤口管理对于预防感染疾病和截肢等併发症至关重要。例如，根据美国疾病管制与预防美国(CDC) 的报告，超过 3,800 万美国人患有糖尿病（约占美国人口的十分之一），其中约 90% 至 95% 患有第 2 型糖尿病。

人们对易于取得的非处方创伤护理产品的需求日益增长，这些产品能够有效管理轻微伤口并防止其恶化。先进的非处方创伤护理产品为糖尿病患者提供了一种便捷的居家伤口护理方式，减少了频繁就医的需求。糖尿病患者日益增长的自我护理需求，推动了美国先进创伤护理非处方药产业的扩张。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国高阶创伤护理OTC市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 补贴市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国先进创伤护理OTC市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国高阶创伤护理OTC市场：产品评估与趋势分析

  • 细分仪表板
  • 美国先进创伤护理OTC市场波动分析
  • 美国高级创伤护理OTC 市场规模和趋势分析（按产品，2021-2033 年）
  • 泡棉敷料
    • 胶水
    • 非黏性泡棉敷料
  • 膜敷料
  • 亲水胶体
  • 水凝胶敷料
  • 蜂蜜酱
  • 油性纱布
  • 不织布术后敷料
  • 其他的

第五章美国高阶创伤护理OTC市场：应用评估与趋势分析

  • 细分仪表板
  • 美国先进创伤护理OTC市场波动分析
  • 2021 年至 2033 年美国高阶创伤护理OTC 市场规模及应用趋势分析
  • 慢性伤口
    • 糖尿病足溃疡（1期、2期、3期、4期、深层组织损伤）
    • 压疮
    • 静脉性腿部溃疡
    • 其他慢性伤口
  • 急性伤口
    • 外科性创伤和外伤（包括皮肤撕裂）
    • 烧烫伤

第六章美国高阶创伤护理OTC市场：通路评估与趋势分析

  • 细分仪表板
  • 美国先进创伤护理OTC市场波动分析
  • 美国高级创伤护理OTC 市场规模及趋势分析（按分销管道），2021 年至 2033 年
  • 零售药局/药局
  • 电子商务/网路药局/健康相关电子商务
  • 其他的

第七章 竞争态势

  • 市场参与企业分类
  • 主要企业简介
  • Company Share Analysis, 2024
    • 史密斯侄子
    • 溶剂
    • Mölnlycke Healthcare AB
    • 3M
    • 康维泰克公司
    • 馄饨
    • Vomaris Innovations公司
    • B. 布朗 SE
    • 康乐保集团
    • 保罗哈特曼股份公司
    • 拜尔斯道夫
    • 迪莫拉医疗
    • Remedy 保健产品
    • 索诺玛製药公司
    • 康德乐
    • 德罗亚尔工业公司
    • 梅德林工业公司
    • 馄饨
Product Code: GVR-4-68040-632-2

U.S. Advanced Wound Care OTC Market Summary

The U.S. advanced wound care OTC market size was estimated at USD 2.77 billion in 2024 and is projected to reach USD 6.61 billion by 2033, growing at a CAGR of 10.33% from 2025 to 2033. The growth is driven by the increasing prevalence of acute wounds, such as surgical wounds, traumatic injuries, and burns, which require effective and immediate wound management solutions.

Rising rates of road accidents, sports injuries, and surgical procedures globally have led to a surge in demand for advanced OTC wound care products that promote faster healing and reduce the risk of infection. According to the data published by the Total Family Care Center in April 2025, approximately 11 million individuals in the U.S. experience acute wounds annually, with around 300,000 cases requiring hospital care. In addition, the growing awareness among consumers regarding proper wound care practices and the ease of access to advanced dressings through retail pharmacies and online platforms continue to support market expansion.

The high and rising prevalence of diabetes in the U.S. significantly drives the growth of the market. Diabetes is a significant risk factor for the development of chronic wounds, particularly diabetic foot ulcers, which require timely and effective wound management to prevent complications such as infections and amputations. For instance, the Centers for Disease Control and Prevention (CDC) reports that more than 38 million Americans have diabetes (about 1 in 10), and about 90% to 95% of them have type 2 diabetes.

There is an increasing demand for accessible, over-the-counter wound care products that allow individuals to manage minor wounds and prevent them from worsening. Advanced OTC wound care solutions offer diabetic patients a convenient way to treat wounds at home, reducing the need for frequent clinical visits. This growing need for self-care solutions among the diabetic population is a key factor propelling the expansion of the U.S. advanced wound care OTC industry.

U.S. Advanced Wound Care OTC Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. advanced wound care OTC market report based on product, application, and distribution channel.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Foam Dressings
    • Adhesive
    • Non-adhesive Foam Dressings
  • Film Dressings
  • Hydrocolloids
  • Hydrogel Dressings
  • Honey Dressings
  • Greasy Gauzes
  • Non-Woven Post Operative Dressings
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Chronic Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers (Stage 1, Stage 2, Stage 3, Stage 4, and Deep Tissue Injury included)
    • Venous Leg Ulcers
    • Other Chronic Wounds
  • Acute Wounds
    • Surgical & Traumatic Wounds (skin tears included)
    • Burns
    • 1st degree burns
    • 2nd degree burns
    • 3rd degree burns
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Retail Pharmacies / Drugstores
  • E-commerce/Online Pharmacies / Health E-tailers
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Advanced Wound Care OTC Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing adoption of digital distribution platforms
      • 3.2.1.2. Rising burden of wounds
      • 3.2.1.3. Increasing approvals for advanced wound care OTC products
      • 3.2.1.4. Rising aging population in the U.S.
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product recalls
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Shift from institutional settings to home care
      • 3.2.3.2. Increasing number of road accidents and injuries
      • 3.2.3.3. Expansion opportunity in post-surgical wound management
    • 3.2.4. Market Challenge Analysis
  • 3.3. U.S. Advanced Wound Care OTC Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Advanced Wound Care OTC Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Advanced Wound Care OTC Market Movement Analysis
  • 4.3. U.S. Advanced Wound Care OTC Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
  • 4.4. Foam Dressings
    • 4.4.1. Foam Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Adhesive
      • 4.4.2.1. Adhesive Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Non-adhesive Foam Dressings
      • 4.4.3.1. Non-adhesive Foam Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Film Dressings
    • 4.5.1. Film Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Hydrocolloids
    • 4.6.1. Hydrocolloids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Hydrogel Dressings
    • 4.7.1. Hydrogel Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Honey Dressings
    • 4.8.1. Honey Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Greasy Gauzes
    • 4.9.1. Greasy Gauzes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Non-Woven Post Operative Dressings
    • 4.10.1. Non-Woven Post Operative Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Others
    • 4.11.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Advanced Wound Care OTC Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Advanced Wound Care OTC Market Movement Analysis
  • 5.3. U.S. Advanced Wound Care OTC Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Chronic Wounds
    • 5.4.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Diabetic Foot Ulcers (Stage 1, Stage 2, Stage 3, Stage 4 and Deep Tissue Injury included)
      • 5.4.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Pressure Ulcers
      • 5.4.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. Venous Leg Ulcers
      • 5.4.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.5. Other Chronic Wounds
      • 5.4.5.1. Other Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Acute Wounds
    • 5.5.1. Acute Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Surgical & Traumatic Wounds (skin tears included)
      • 5.5.2.1. Surgical & Traumatic Wounds (skin tears included) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Burns
      • 5.5.3.1. Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.3.2. 1st Degree Burns
        • 5.5.3.2.1. 1st Degree Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.3.3. 2nd Degree Burns
        • 5.5.3.3.1. 2nd Degree Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.3.4. 3rd Degree Burns
        • 5.5.3.4.1. 3rd Degree Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Advanced Wound Care OTC Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Advanced Wound Care OTC Market Movement Analysis
  • 6.3. U.S. Advanced Wound Care OTC Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 6.4. Retail Pharmacies / Drugstores
    • 6.4.1. Retail Pharmacies / Drugstores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. E-commerce/Online Pharmacies / Health E-tailers
    • 6.5.1. E-commerce/Online Pharmacies / Health E-tailers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
  • 7.3. Company Share Analysis, 2024
    • 7.3.1. Smith+Nephew
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Solventum
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Molnlycke Health Care AB
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. 3M
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Convatec Inc.
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Lavior
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Vomaris Innovations, Inc.
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. B. Braun SE
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Coloplast Group
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. PAUL HARTMANN AG
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Product Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. Beiersdorf
      • 7.3.11.1. Company Overview
      • 7.3.11.2. Financial Performance
      • 7.3.11.3. Product Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. Dimora Medical
      • 7.3.12.1. Company Overview
      • 7.3.12.2. Financial Performance
      • 7.3.12.3. Product Benchmarking
      • 7.3.12.4. Strategic Initiatives
    • 7.3.13. Remedium Healthcare Products
      • 7.3.13.1. Company Overview
      • 7.3.13.2. Financial Performance
      • 7.3.13.3. Product Benchmarking
      • 7.3.13.4. Strategic Initiatives
    • 7.3.14. Sonoma Pharmaceuticals, Inc.
      • 7.3.14.1. Company Overview
      • 7.3.14.2. Financial Performance
      • 7.3.14.3. Product Benchmarking
      • 7.3.14.4. Strategic Initiatives
    • 7.3.15. Cardinal Health
      • 7.3.15.1. Company Overview
      • 7.3.15.2. Financial Performance
      • 7.3.15.3. Product Benchmarking
      • 7.3.15.4. Strategic Initiatives
    • 7.3.16. DeRoyal Industries, Inc.
      • 7.3.16.1. Company Overview
      • 7.3.16.2. Financial Performance
      • 7.3.16.3. Product Benchmarking
      • 7.3.16.4. Strategic Initiatives
    • 7.3.17. Medline Industries, LP
      • 7.3.17.1. Company Overview
      • 7.3.17.2. Financial Performance
      • 7.3.17.3. Product Benchmarking
      • 7.3.17.4. Strategic Initiatives
    • 7.3.18. Lavior
      • 7.3.18.1. Company Overview
      • 7.3.18.2. Financial Performance
      • 7.3.18.3. Product Benchmarking
      • 7.3.18.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. U.S. Advanced Wound Care OTC Market, by Product, 2021 - 2033 (USD Million)
  • Table 4. U.S. Advanced Wound Care OTC Market, by Application, 2021 - 2033 (USD Million)
  • Table 5. U.S. Advanced Wound Care OTC Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 6. Participant's Overview
  • Table 7. Financial Performance
  • Table 8. Product Benchmarking
  • Table 9. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Advanced Wound Care OTC Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 U.S. Advanced Wound Care OTC Market, for Product, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Advanced Wound Care OTC Market, for Foam Dressings, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Advanced Wound Care OTC Market, for Adhesive, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Advanced Wound Care OTC Market, for Non-adhesive foam dressings, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Advanced Wound Care OTC Market, for Film Dressings, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Advanced Wound Care OTC Market, for Hydrocolloids, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Advanced Wound Care OTC Market, for Hydrogel Dressings, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Advanced Wound Care OTC Market, for Honey Dressings, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Advanced Wound Care OTC Market, for Greasy Gauzes, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Advanced Wound Care OTC Market, for Non-Woven Post Operative Dressings, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. Advanced Wound Care OTC Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Advanced Wound Care OTC Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. Advanced Wound Care OTC Market, for Chronic Wounds, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. Advanced Wound Care OTC Market, for Diabetic Foot Ulcers, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Advanced Wound Care OTC Market, for Pressure Ulcers, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Advanced Wound Care OTC Market, for Venous Leg Ulcers, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. Advanced Wound Care OTC Market, for Other Chronic Wounds, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Advanced Wound Care OTC Market, for Acute Wounds, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Advanced Wound Care OTC Market, for Surgical & Traumatic Wounds (skin tears included), 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Advanced Wound Care OTC Market, for Burns, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. Advanced Wound Care OTC Market, for 1st Degree Burns, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. Advanced Wound Care OTC Market, for 2nd Degree Burns, 2021 - 2033 (USD Million)
  • Fig. 36 U.S. Advanced Wound Care OTC Market, for 3rd Degree Burns, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. Advanced Wound Care OTC Market, for Distribution Channel, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. Advanced Wound Care OTC Market, for Retail Pharmacies / Drugstores, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. Advanced Wound Care OTC Market, for E-commerce/Online Pharmacies / Health E-tailers, 2021 - 2033 (USD Million)
  • Fig. 40 U.S. Advanced Wound Care OTC Market, for Others, 2021 - 2033 (USD Million)